图表内容
图表39公司正在开发多款mRNA疫苗
Program
Indication
Discovery
Preclinical
Phase I
mRNA-1730
COVID-19 vaccine
mRNA-1740
Flu vaccine
mRNA-1750
Rabies vaccine
mRNA-1760
HSV vaccine
mRNA-1770
RSV vaccine
mRNA-1521
RAS pan-cancer vaccine
mRNA-1523
PD-L1 mRNA encoded antibody
mRNA-1525
Personalized cancer vaccine
餐科来源:公司官网,平安证券研究所